CAR19BCMA-T cells

GENETIC2 trials

Sponsors

Affiliated Hospital to Academy of Military Medical Sciences, Chinese PLA General Hospital

Conditions

Lymphomas/Leukemias With Plasmacytic DifferentiationRelapsed or Refractory Plasma Cell Neoplasms

Early Phase 1

CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation

Not yet recruitingNCT06986434

Affiliated Hospital to Academy of Military Medical SciencesLymphomas/Leukemias With Plasmacytic Differentiation, Relapsed or Refractory Plasma Cell Neoplasms

Start: 2026-04-02End: 2028-08-25Target: 20Updated: 2026-04-08

CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms

Not yet recruitingNCT07077330

Chinese PLA General HospitalRelapsed or Refractory Plasma Cell Neoplasms

Start: 2025-08-01End: 2027-08-01Target: 20Updated: 2025-07-22